Articles

MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma

MD Anderson Cancer Center, Houston, USA & Henan Provincial People Hospital, China;
Dept of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA;
Dept of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA;
Dept of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA;
MD Anderson Cancer Center, Houston, USA & National Cancer Center, Beijing, China;
Dept of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA;
Dept. of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA;
Dept. of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA;
Dept. of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA
Dept. of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA
Haematologica Early view Apr 9, 2020 https://doi.org/10.3324/haematol.2019.243071